N-5355

N/A

Report date: 2022/10/25 14:55:43
NME

Base Information

Drug NameN-5355
Drug Alias NameN-5355
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTRAF2 and NCK-interacting protein kinase inhibitorsWnt signalling pathway inhibitors
TargetsTRAF2 and NCK-interacting protein kinase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCarna Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesCarna Biosciences Inc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A